missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human ErbB2/Her2 F(ab')2 (Research Grade Trastuzumab Biosimilar) Antibody, R&D Systems™

Human Monoclonal Antibody
Marque: R&D Systems MAB11043-SP
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
ErbB2/Her2 Monoclonal antibody specifically detects ErbB2/Her2 in Human samples. It is validated for Immunocytochemistry
Spécification
| ErbB2/Her2 | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS. | |
| Human | |
| Protein A or G purified from cell culture supernatant | |
| RUO | |
| 2064 | |
| Human | |
| Purified |
| Immunocytochemistry | |
| Hu5F2 | |
| Immunocytochemistry 5-25 ug/mL | |
| CD340, CD340 antigen, c-erb B2/neu protein, EC 2.7.10, EGFR2, HER2, HER-2, HER2EC 2.7.10.1, herstatin, Metastatic lymph node gene 19 protein, MLN 19, MLN19, Neu Oncogene, NEUHER-2/neu, neuroblastoma/glioblastoma derived oncogene homolog, NGL, NGLTKR1, p185erbB2, Proto-oncogene c-ErbB-2, Proto-oncogene Neu, receptor tyrosine-protein kinase erbB-2, TKR1, Tyrosine kinase-type cell surface receptor HER2, v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2(neuro/glioblastoma derived oncogene homolog), v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastomaderived oncogene homolog (avian) | |
| Human ErbB2/Her2, | |
| 25 μg | |
| Primary | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution. | |
| IgG1 |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu